CompletedNCT05841030
Care patterns for depression with anhedonia and limited medication response
About this title
Read the official source —Observational studyAges 18–74Multiple countries
Understand this study
Who was this study for?
Listed age limits: 18 years to 74 years.
- Listed locations
- Birmingham and 94 more locationsSee all locations and recruitment
Study information
Study start dateStarted: April 28, 2023
- Recruitment status
- Completed
- Enrollment listed in the registry
- 545
- Sponsor
- Janssen Research & Development, LLC
- Sponsor type
- Other organization
- Study type
- Observational
- Intervention type
- OTHER
- Study phase
- Not clearly listed
- Locations
- United States, France, Canada, ...
- Age range
- From 18 Years to 74 Years
- Official registry ID
- NCT05841030
- Official title
Show the full official title
A Study of Disease Characteristics and Real-life Standard of Care Effectiveness in Patients With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including an SSRI or SNRI
Get this study by email
Recruitment & locations
CompletedBirmingham, United States · Homewood, United States · California City, United States
79 more locations
- Farmington, United States
- Saint Augustine, United States
- Sarasota, United States
- Tampa, United States
- Atlanta, United States
- Marietta, United States
- Chicago, United States
- Maywood, United States
- Naperville, United States
- Newton, United States
- Worcester, United States
- Columbia, United States
- Fairlawn, United States
- Allentown, United States
- Tacoma, United States
- Buenos Aires, Argentina
- Ciudad Autonoma Buenos Aires, Argentina
- Córdoba, Argentina
- Mendoza, Argentina
- Passo Fundo, Brazil
- Sao Jose Rio Preto, Brazil
- São Bernardo do Campo, Brazil
- São Paulo, Brazil
- West Vancouver, Canada
- Kingston, Canada
- Ontario, Canada
- Toronto, Canada
- Angers, France
- Clermont-Ferrand, France
- Douai, France
- Isere, France
- Montpellier, France
- Nantes, France
- Paris, France
- Toulon, France
- Aachen, Germany
- Berlin, Germany
- Frankfurt, Germany
- Jena, Germany
- Mainz, Germany
- Mittweida, Germany
- Nuremberg, Germany
- Oranienburg, Germany
- Stralsund, Germany
- Colleferro, Italy
- Genova, Italy
- Lecce, Italy
- Milan, Italy
- Parma, Italy
- Perugia, Italy
- Roma, Italy
- Siena, Italy
- Daegu, South Korea
- Goyang, South Korea
- Incheon, South Korea
- Jeju Special, South Korea
- Seoul, South Korea
- Barcelona, Spain
- Collado Villalba, Spain
- Jerez de la Frontera, Spain
- Madrid, Spain
- Málaga, Spain
- Ponferrada, Spain
- Valencia, Spain
- Zamora, Spain
- Gustavsberg, Sweden
- Halmstad, Sweden
- Lund, Sweden
- Skövde, Sweden
- Chertsey, United Kingdom
- Derby, United Kingdom
- Exeter, United Kingdom
- London, United Kingdom
- Manchester, United Kingdom
- Newcastle upon Tyne, United Kingdom
- Sleaford, United Kingdom
- Southampton, United Kingdom
- Stafford, United Kingdom
- Wakefield, United Kingdom
Questions about this study
Who is behind this study?
The study sponsor is Janssen Research & Development, LLC.
Who was this study for?
Listed age limits: 18 years to 74 years.
